Rankings
▼
Calendar
LAB (Standard BioTools Inc.) Stock Financials & Earnings | Market Cap Arena
LAB
Standard BioTools Inc.
Mkt Cap
$388M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$85M
Net Income (TTM)
-$75M
EPS (TTM)
-$0.20
Free Cash Flow (TTM)
-$83M
Gross Margin
49.9%
Op. Margin
-109.3%
Net Margin
-87.8%
FCF Margin
-96.9%
P/S Ratio (TTM)
4.6x
P/E Ratio (TTM)
—
YoY Rev Growth
-46.6%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$25M
$12M
-$17M
Q2 23
$28M
$14M
-$17M
Q3 23
$25M
$11M
-$21M
Q4 23
$28M
$13M
-$21M
Q1 24
$46M
$24M
-$60M
Q2 24
$22M
$10M
-$30M
Q3 24
$45M
$23M
-$32M
Q4 24
$47M
$22M
-$33M
Q1 25
$41M
$20M
-$33M
Q2 25
$22M
$11M
-$26M
Q3 25
$20M
$9M
-$23M
Q4 25
$3M
$3M
-$11M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
4.0x
—
Q2 23
3.7x
—
Q3 23
3.7x
—
Q4 23
3.7x
—
Q1 24
3.1x
—
Q2 24
3.2x
—
Q3 24
2.8x
—
Q4 24
2.4x
—
Q1 25
2.5x
—
Q2 25
2.5x
—
Q3 25
3.0x
—
Q4 25
4.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$8M
-$9M
Q2 23
-$9M
-$10M
Q3 23
-$11M
-$12M
Q4 23
-$14M
-$14M
Q1 24
-$62M
-$63M
Q2 24
-$39M
-$41M
Q3 24
-$28M
-$30M
Q4 24
-$14M
-$17M
Q1 25
-$30M
-$35M
Q2 25
-$21M
-$23M
Q3 25
-$22M
-$23M
Q4 25
-$1M
-$2M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$1M
Q2 23
$838K
Q3 23
$905K
Q4 23
$78K
Q1 24
$781K
Q2 24
$2M
Q3 24
$2M
Q4 24
$3M
Q1 25
$5M
Q2 25
$2M
Q3 25
$886K
Q4 25
$476K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-5.2%
-22.8%
Q2 23
+47.3%
-21.3%
Q3 23
-1.1%
-14.9%
Q4 23
+4.3%
+3.0%
Q1 24
+81.3%
+153.5%
Q2 24
-18.7%
+16.9%
Q3 24
+77.3%
+64.8%
Q4 24
+65.7%
+60.4%
Q1 25
-10.4%
-30.2%
Q2 25
-3.2%
-10.0%
Q3 25
-56.5%
-43.9%
Q4 25
-93.1%
-81.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
12.5%
Q2 23
$3M
11.3%
Q3 23
$3M
13.3%
Q4 23
$3M
12.3%
Q1 24
$4M
7.8%
Q2 24
$7M
29.9%
Q3 24
$6M
13.2%
Q4 24
$7M
16.0%
Q1 25
$9M
22.1%
Q2 25
$5M
24.7%
Q3 25
$8M
38.5%
Q4 25
$6M
178.2%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$6M
$21M
Q2 23
$6M
$23M
Q3 23
$6M
$22M
Q4 23
$7M
$21M
Q1 24
$16M
$47M
Q2 24
$7M
$25M
Q3 24
$13M
$34M
Q4 24
$14M
$38M
Q1 25
$11M
$39M
Q2 25
$6M
$28M
Q3 25
$6M
$27M
Q4 25
$8M
$25M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
Revenue by Geography
Americas
Asia Pacific
Emea
Quarter
Americas
Asia Pacific
Emea
Q1 23
$12M
$6M
$8M
Q2 23
$10M
$6M
$11M
Q3 23
$11M
$6M
$8M
Q4 23
$13M
$6M
$9M
Q1 24
$25M
$8M
$13M
Q3 24
$24M
$5M
$16M
Q1 25
$19M
$9M
$13M
Q2 25
$9M
$4M
$9M
Q3 25
$8M
$4M
$7M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$114M
$41M
$155M
Q2 23
$142M
$0
$142M
Q3 23
$80M
$49M
$129M
Q4 23
$52M
$63M
$115M
Q1 24
$287M
$175M
$462M
Q2 24
$270M
$125M
$395M
Q3 24
$211M
$156M
$366M
Q4 24
$167M
$126M
$293M
Q1 25
$151M
$107M
$258M
Q2 25
$159M
$78M
$237M
Q3 25
$129M
$65M
$195M
Q4 25
$118M
$69M
$188M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
79M
-0.4%
Q2 23
79M
-0.5%
Q3 23
79M
+0.6%
Q4 23
80M
+0.7%
Q1 24
294M
+268.9%
Q2 24
372M
+26.6%
Q3 24
372M
-0.2%
Q4 24
375M
+0.8%
Q1 25
378M
+1.0%
Q2 25
380M
+0.6%
Q3 25
383M
+0.6%
Q4 25
385M
+0.6%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$246K
474
FY 15
$196K
584
FY 16
$177K
589
FY 17
$202K
505
FY 18
$211K
535
FY 19
$207K
566
FY 20
$220K
627
FY 21
$212K
615
FY 22
$187K
523
FY 23
$115K
928
FY 24
$213K
818
FY 25
$104K
818
marketcaparena.com